Indian Pharmaceutical Company Opens a R&D Center for Inhalation Products in the US

Lupin’s center at Florida will focus on developing inhalation products for the treatment of asthma, allergic rhinitis and other lung diseases.

Lupin, a pharmaceutical company has opened a research and development center for inhalation products in Florida, the US.

The facility at Coral Springs, Florida, will focus on the research and development of inhalation products for the treatment of asthma, allergic rhinitis, chronic obstructive pulmonary diseases and other lung diseases.

Pivotal Expansion: Lupin Pharmaceuticals Acquires US-Based Gavis for $880 Million
In a pivotal move to expand their global presence, an Indian Pharmaceutical company- Lupin Pharmaceuticals, acquired Gavis, a US- based privately- held company.

"With the talent and resources this state provides, our Coral Springs expansion will further strengthen our ability to bring quality, affordable pharmaceuticals to patients in the United States and other key markets globally," said Vinita Gupta, Lupin CEO.

Source-PTI

Hyderabad-Based Pharmaceutical Company Launches Biosimilar Rituximab in India
Rituximab is used alone or with other drugs to treat non-Hodgkin's lymphoma, chronic lymphocytic leukaemia and rheumatoid arthritis.

Indian Pharamaceutical Company Receives USFDA�s Nod for Asthma Treatment Drugs
Ajanta Pharma will soon launch its generic montelukast tablets and oral granules that helps in treating asthma and seasonal hay fever.

Indian Pharmaceutical Industry can Gain from Africa's Growing Drug Market: Report
The worldwide demand for cost-effective generic drugs is leading India to rise as a hub of generic drug manufacturing, reveals a global consultancy.